Basic info
Industry
biotechnology research
Sectors
Biotechnology
Medical Device
Health Care
Rare Subsets of Diabetic Nephropathy
Therapeutics
Kidney Disease
Focal Segmental Glomerulosclerosis (FSGS)
Precision Medicine
Date founded
2016
Funding rounds raised
Total raised
$100M
from 7 investors over 7 rounds
G
Goldfinch Bio raised $100M on June 30, 2020
Investors: Irving Investors, Eventide Asset Management, Casdin Capital, LLC, Gilead Sciences and Wellington Management
G
Goldfinch Bio raised $55M on May 8, 2019
Investors: Gilead Sciences
G
Goldfinch Bio raised $55M on December 14, 2016
Investors: Third Rock Ventures